Phenytoin Sodium Injection
Product Images NDC 0404-9808

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Phenytoin Sodium (NDC 0404-9808). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure of phenytoin sodium showing its molecular formula C15H11N2NaO2 and molecular weight 274.25.*
FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
Table listing drugs that affect phenytoin concentrations. It categorizes interacting agents into those that may increase, decrease, or either increase or decrease phenytoin serum levels, with examples for each category such as antiepileptic drugs, azoles, antineoplastic agents, antidepressants, gastric acid reducing agents, sulfonamides, antiviral agents, and others.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
A table titled 'Drugs Affected by Phenytoin' listing interacting agents and examples under two main categories: drugs whose efficacy is impaired by phenytoin (including azoles, antineoplastic agents, delavirdine, neuromuscular blocking agents, warfarin, and others) and drugs whose level is decreased by phenytoin (including antiepileptic drugs, antilipidemic agents, antiviral agents, calcium channel blockers, and others). Additional notes on interactions are included.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Label for Phenytoin Sodium Injection USP, 50 mg/mL strength, in a 5 mL single-dose vial. The label indicates use for intravenous or intramuscular administration with dosing instructions to not exceed 50 mg per minute intravenously. Packaged by Henry Schein, Inc., located in Bastian, VA. Includes storage instructions and a barcode with NDC 0404-9808-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.